Wei-Ting Chen Selected Research

hyperforin

10/2020	Hyperforin induces apoptosis through extrinsic/intrinsic pathways and inhibits EGFR/ERK/NF-κB-mediated anti-apoptotic potential in glioblastoma.
1/2018	Hyperforin Suppresses Tumor Growth and NF-κB-mediated Anti-apoptotic and Invasive Potential of Non-small Cell Lung Cancer.
1/2017	Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wei-Ting Chen Research Topics

Disease

35	Neoplasms (Cancer) 10/2022 - 09/2007
34	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 01/2007
14	Infections 04/2022 - 05/2010
7	Chronic Hepatitis C 03/2022 - 10/2013
7	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 03/2011
6	Fibrosis (Cirrhosis) 01/2022 - 05/2007
6	Inflammation (Inflammations) 12/2021 - 12/2016
6	Myocardial Infarction 10/2021 - 05/2014
5	Heart Arrest (Cardiac Arrest) 12/2022 - 11/2015
5	Infarction (Infarctions) 10/2021 - 02/2015
4	Sepsis (Septicemia) 04/2022 - 05/2007
4	Body Weight (Weight, Body) 12/2021 - 01/2014
4	Neoplasm Metastasis (Metastasis) 10/2020 - 01/2018
4	Pancreatic Neoplasms (Pancreatic Cancer) 09/2019 - 01/2017
3	Insulin Resistance 12/2021 - 01/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2021 - 01/2018
3	Hyperthermia 01/2020 - 01/2019
2	Heart Failure 01/2022 - 05/2014
2	Hepatitis 01/2022 - 01/2014
2	Cardiac Arrhythmias (Arrythmia) 10/2021 - 01/2021
2	End Stage Liver Disease 01/2021 - 12/2014
2	Acute-On-Chronic Liver Failure 01/2021 - 12/2014
2	Lung Neoplasms (Lung Cancer) 06/2020 - 02/2019
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2017
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2020 - 05/2014
2	Sarcopenia 10/2019 - 01/2019
2	Leukemia 02/2019 - 01/2017
2	Pneumonia (Pneumonitis) 02/2019 - 07/2015
2	Carcinogenesis 02/2019 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 10/2015
2	Mycoses (Diseases, Fungus) 06/2018 - 02/2018
2	Communicable Diseases (Infectious Diseases) 06/2018 - 02/2018
2	Hematologic Neoplasms (Hematological Malignancy) 06/2018 - 11/2009
2	Liver Diseases (Liver Disease) 01/2018 - 01/2017
2	Chronic Hepatitis B 01/2018 - 05/2010
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016 - 07/2015
2	Hemorrhage 12/2014 - 04/2011
2	Pancreatitis 01/2011 - 05/2007
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 11/2022
1	Seizures (Absence Seizure) 05/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 04/2022
1	Rhabdomyolysis 04/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 11/2021 - 01/2012
6	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2014
5	InterferonsIBA 01/2021 - 10/2013
4	BilirubinIBA 03/2022 - 04/2015
4	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2020 - 09/2018
4	Anti-Bacterial Agents (Antibiotics)IBA 10/2019 - 11/2009
4	Amyloid (Amyloid Fibrils)IBA 01/2017 - 03/2011
3	Particulate MatterIBA 11/2022 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2017
3	tazobactam drug combination ceftolozaneIBA 04/2022 - 10/2019
3	Sorafenib (BAY 43-9006)FDA Link 02/2022 - 01/2014
3	VaccinesIBA 01/2022 - 02/2018
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022 - 08/2015
3	Pharmaceutical PreparationsIBA 01/2022 - 02/2018
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 01/2017
3	amentoflavoneIBA 03/2021 - 09/2017
3	hyperforinIBA 10/2020 - 01/2017
3	Antifungal AgentsIBA 06/2018 - 11/2011
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 07/2015
2	AlbuminsIBA 03/2022 - 01/2022
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2021
2	CalciumIBA 01/2022 - 01/2011
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2011
2	AutoantibodiesIBA 01/2022 - 06/2016
2	Connexin 43 (Connexin43)IBA 10/2021 - 01/2020
2	Nerve Growth Factor (NGF)IBA 01/2021 - 01/2021
2	Complement System Proteins (Complement)IBA 01/2021 - 01/2020
2	Chlorogenic AcidIBA 01/2020 - 01/2019
2	Neuroprotective AgentsIBA 01/2020 - 11/2018
2	Ribavirin (Virazole)FDA LinkGeneric 12/2019 - 10/2013
2	DNA (Deoxyribonucleic Acid)IBA 06/2019 - 01/2017
2	Superoxides (Superoxide)IBA 03/2019 - 02/2015
2	Protein CIBA 02/2019 - 01/2017
2	X-Linked Inhibitor of Apoptosis ProteinIBA 02/2019 - 01/2017
2	EnzymesIBA 02/2019 - 01/2018
2	NF-kappa B (NF-kB)IBA 11/2018 - 09/2018
2	CytokinesIBA 11/2018 - 12/2017
2	Cytidine Triphosphate (CTP)IBA 12/2016 - 12/2014
2	Alemtuzumab (Campath)FDA Link 01/2016 - 11/2011
2	Monoclonal AntibodiesIBA 10/2015 - 11/2011
2	Ethanol (Ethyl Alcohol)IBA 08/2014 - 03/2008
2	HLA-DR Antigens (HLA-DR)IBA 01/2011 - 05/2007
2	Interleukin-10 (Interleukin 10)IBA 01/2011 - 05/2007
1	Blood Glucose (Blood Sugar)IBA 05/2022
1	ChAdOx1 nCoV-19IBA 04/2022

Therapy/Procedure

21	Therapeutics 02/2022 - 11/2011
15	Radiofrequency Ablation 10/2022 - 09/2007
7	Drug Therapy (Chemotherapy) 03/2021 - 12/2015
4	Induced Hypothermia 12/2022 - 01/2020
4	Electrodes (Electrode) 01/2021 - 01/2007
3	Cardiopulmonary Resuscitation (CPR) 01/2022 - 01/2014
3	Transplantation 06/2018 - 02/2015
3	Aftercare (After-Treatment) 01/2018 - 12/2014
2	Proton Therapy 03/2022 - 01/2018
2	Ablation Techniques 11/2021 - 09/2007
2	Radiotherapy 01/2020 - 11/2013
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2016 - 07/2015
2	Catheters 06/2011 - 11/2009